Loading organizations...
Loading organizations...
Authorea is a technology company.
Authorea provides a web-based platform for scientific authors, streamlining collaborative writing, data hosting, and publication. This integrated environment supports researchers through manuscript drafting, citation management, and preprint dissemination. Its technical foundation emphasizes structured authoring and version control, ensuring transparency and accuracy in scholarly communication.
Authorea was co-founded in 2012 by Alberto Pepe and Nathan Jenkins. Their partnership arose from shared frustration with traditional academic publishing's inefficiencies. Alberto Pepe, leveraging his astrophysics background and CERN experience, identified a crucial need for a more effective system to create and share scientific content.
The platform serves a global community of researchers seeking efficiency and openness in their academic pursuits. Authorea’s vision is to transform how scientific output is created and consumed, making research more discoverable, accessible, and citable. Empowering scientists with collaboration and open dissemination tools, the company accelerates discovery and knowledge sharing.
Authorea has raised $2.6M across 2 funding rounds.
Authorea has raised $2.6M in total across 2 funding rounds.
Authorea has raised $2.6M in total across 2 funding rounds.
Authorea's investors include Knight Foundation, Sam Arbesman, Bloomberg Beta, Bonin Ventures, Bowery Capital, Bridge Angel Investors, FLORA Ventures, Nielsen Innovate, Rashaun Williams, ff Venture Capital, New York Angels, John Frankel.
Authorea is a collaborative online platform designed for researchers to write, cite, collaborate, host data, and publish scientific documents, supporting markup languages, citations, graphs, and interactive elements across disciplines from astrophysics to zoology.[1][2][3][7] It serves academic and research communities worldwide, solving the limitations of traditional tools like PDFs by enabling web-first, data-driven, interactive, and reproducible research workflows with features such as one-click citations, Git-based repositories for code and data, and real-time collaboration.[1][2][4][7] Founded in 2012-2014, Authorea raised $2.11M before its 2018 acquisition by Atypon (part of Wiley), which accelerated its development into an open science ecosystem tool, attracting tens of thousands of users in fields like medicine, genomics, and computational biology.[2][3][4][5]
Authorea was founded in late 2012 in New York by a team frustrated with outdated writing tools that failed to meet researchers' needs in a web-first world, aiming to create a modern document editor for scientific collaboration.[2][3] The idea emerged from recognizing the internet age's lack of advanced tools for research writing, leading to a platform that supports markup, integrations, and open sharing.[1][2] Early traction included rapid growth among hard sciences researchers, with examples like an Ebola paper garnering 25 scientist contributions before Cell publication, and funding rounds totaling $2.11M, including a $1.5M raise to advance open, reproducible research.[4][6][8] A pivotal moment came in 2018 when Atypon acquired Authorea (alongside Manuscripts), integrating it into Wiley's ecosystem for enhanced investment, open-source development, and HTML-first publishing tools.[1][3][5]
Authorea rides the open science trend toward transparency, reproducibility, and web-native research, addressing PDF lock-in amid rising demands for data/code sharing in academia (20M researchers, 200M students globally).[4][5] Its timing aligns with HTML-first publishing, linked data, and collaborative preprints, amplified by the 2018 Atypon/Wiley acquisition amid open access pushes by publishers like Wiley.[1][3][5] Market forces like AI-driven research tools (e.g., Iris.ai, ReadCube competitors) and institutional needs for efficient workflows favor it, influencing the ecosystem by catalyzing interactive platforms, peer review evolution, and integration into publishing pipelines.[3][4][5]
Post-acquisition, Authorea is evolving into a re-engineered, open-source authoring suite integrated with Wiley's discovery and publishing tools, prioritizing speed, robustness, and broader publisher adoption.[3][5] Trends like AI-assisted literature tools, reproducible research mandates, and collaborative preprints will shape its growth, potentially expanding to R&D beyond academia. Its influence may grow by standardizing web-first science, tying back to its core mission of accelerating discovery through modern, collaborative platforms that transform static papers into living, interactive research hubs.[2][5][7]
Authorea has raised $2.6M across 2 funding rounds. Most recently, it raised $2.0M Seed in January 2016.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 1, 2016 | $2.0M Seed | Knight Foundation, Sam Arbesman | Bloomberg Beta, Bonin Ventures, Bowery Capital, Bridge Angel Investors, FLORA Ventures, Nielsen Innovate, Rashaun Williams, ff Venture Capital, New York Angels |
| Sep 22, 2014 | $610K Seed | John Frankel, New York Angels |